ArticleFrontiers in oncology2022

Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy.

Yuanyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.